PedAM
Pediatric Disease Annotations & Medicines
| Disease | sudden cardiac death |
| Phenotype | C0007194|hypertrophic cardiomyopathy |
| Sentences | 15 |
| PubMedID- 26257460 | The main problem in elite athletes is the differentiation between physiologic left ventricular hypertrophy, due to sustained physical training, and pathologic lvh due to hypertrophic cardiomyopathy, associated with sudden cardiac death [87]. |
| PubMedID- 25057223 | hypertrophic cardiomyopathy's (hcm) association with sudden cardiac death is well recognised. |
| PubMedID- 23339826 | A validation study of the 2003 american college of cardiology/european society of cardiology and 2011 american college of cardiology foundation/american heart association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. |
| PubMedID- 25648421 | Qrs fragmentation and qtc duration relate to malignant ventricular tachyarrhythmias and sudden cardiac death in patients with hypertrophic cardiomyopathy. |
| PubMedID- 26363820 | The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy. |
| PubMedID- 26264962 | A second example illustrates the external validation of risk models (based on cox regression) for sudden cardiac death in patients with hypertrophic cardiomyopathy (web appendix). |
| PubMedID- 23355552 | Aborted sudden cardiac death (scd) in a patient with hypertrophic cardiomyopathy (hcm) with low-risk factors for scd. |
| PubMedID- 26414322 | Objectives: extreme left ventricular hypertrophy (lvh) is a known risk factor for sudden cardiac death in hypertrophic cardiomyopathy (hcm). |
| PubMedID- 20019025 | The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein c gene mutation carriers: focus on predictive screening. |
| PubMedID- 25804453 | Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. |
| PubMedID- 20663074 | Introduction: implantable cardioverter-defibrillators (icds) decrease sudden cardiac death in patients with hypertrophic cardiomyopathy (hcm). |
| PubMedID- 25044226 | Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy. |
| PubMedID- 23574968 | Prevention of sudden cardiac death in hypertrophic cardiomyopathy. |
| PubMedID- 20118111 | Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. |
| PubMedID- 23022709 | sudden cardiac death in hypertrophic cardiomyopathy. |
Page: 1